Literature DB >> 32927367

Increased IL-8 concentrations in the cerebrospinal fluid of patients with unipolar depression.

Hanna Kuzior1, Bernd L Fiebich2, Nizar M Yousif2, Soraya W Saliba2, Christiane Ziegler2, Kathrin Nickel1, Simon J Maier1, Patrick Süß3, Kimon Runge1, Miriam Matysik1, Rick Dersch4, Benjamin Berger4, Tilman Robinson4, Nils Venhoff5, Franziska Kessler6, Thomas Blank6, Katharina Domschke7, Ludger Tebartz van Elst1, Dominique Endres8.   

Abstract

INTRODUCTION: Unipolar depression is a common and debilitating disorder. Immunological explanatory approaches have become increasingly important in recent years and can be studied particularly well in the cerebrospinal fluid (CSF). Previous studies discerned alterations in interleukin (IL)-6 and IL-8 levels; however, findings regarding IL-8 were partly contradictory. The aim of the present study was to investigate the concentrations of different cytokines and chemokines, focusing on IL-8, in the CSF of patients with unipolar depression.
MATERIALS AND METHODS: Participants included 40 patients with unipolar depression and 39 mentally healthy controls with idiopathic intracranial hypertension. CSF cytokine levels were measured using a magnetic bead multiplexing immunoassay.
RESULTS: IL-8 levels in the CSF of the patient group with depression were significantly higher than those in the control group (Mean ± SD: 38.44 ± 6.26 pg/ml versus 21.40 ± 7.96 pg/ml; p < .001). LIMITATIONS: The significance of the results is limited by the retrospective design and methodological aspects. DISCUSSION: The main findings of this study were significantly higher concentrations of IL-8 in the CSF of patients with unipolar depression than in the control group. The detection of high CSF IL-8 levels in this study supports the idea that inflammatory processes might play a role in the pathophysiology of a subgroup of patients with depression.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; IL-8; Interleukin 8; Neuroinflammation

Year:  2020        PMID: 32927367     DOI: 10.1016/j.comppsych.2020.152196

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  9 in total

1.  Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Maike Michel; Bernd L Fiebich; Hanna Kuzior; Sophie Meixensberger; Benjamin Berger; Simon Maier; Kathrin Nickel; Kimon Runge; Dominik Denzel; Benjamin Pankratz; Miriam A Schiele; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

2.  Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.

Authors:  Martin Stangel; Klemens Ruprecht; Brigitte Wildemann; Sven Jarius; Florence Pache; Peter Körtvelyessy; Ilijas Jelčić; Mark Stettner; Diego Franciotta; Emanuela Keller; Bernhard Neumann; Marius Ringelstein; Makbule Senel; Axel Regeniter; Rea Kalantzis; Jan F Willms; Achim Berthele; Markus Busch; Marco Capobianco; Amanda Eisele; Ina Reichen; Rick Dersch; Sebastian Rauer; Katharina Sandner; Ilya Ayzenberg; Catharina C Gross; Harald Hegen; Michael Khalil; Ingo Kleiter; Thorsten Lenhard; Jürgen Haas; Orhan Aktas; Klemens Angstwurm; Christoph Kleinschnitz; Jan Lewerenz; Hayrettin Tumani; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2022-01-20       Impact factor: 8.322

3.  Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Kimon Runge; Agnes Balla; Bernd L Fiebich; Simon J Maier; Benjamin Pankratz; Andrea Schlump; Kathrin Nickel; Rick Dersch; Katharina Domschke
Journal:  Fluids Barriers CNS       Date:  2022-07-29

4.  Association Between Inflammatory Biomarkers and Mental Health Symptoms in Middle Eastern Refugees in the US.

Authors:  Malek Ghandour; Jolin B Yamin; Judith E Arnetz; Mark A Lumley; Paul M Stemmer; Paul Burghardt; Hikmet Jamil; Bengt B Arnetz
Journal:  Cureus       Date:  2022-08-21

5.  Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study.

Authors:  Morten Brix Schou; Jeanette Brun Larsen; Astrid Kamilla Stunes; Sverre Georg Sæther
Journal:  Front Psychiatry       Date:  2022-09-12       Impact factor: 5.435

Review 6.  Inflamed brain: Targeting immune changes and inflammation for treatment of depression.

Authors:  Shinji Sakamoto; Xiaolei Zhu; Yuto Hasegawa; Sadik Karma; Mizuho Obayashi; Emily Alway; Atsushi Kamiya
Journal:  Psychiatry Clin Neurosci       Date:  2021-07-28       Impact factor: 12.145

7.  Upregulation of sICAM-1 and sVCAM-1 Levels in the Cerebrospinal Fluid of Patients with Schizophrenia Spectrum Disorders.

Authors:  Sophie Meixensberger; Hanna Kuzior; Bernd L Fiebich; Patrick Süß; Kimon Runge; Benjamin Berger; Kathrin Nickel; Dominik Denzel; Miriam A Schiele; Maike Michel; Simon Maier; Karl Bechter; Katharina Domschke; Ludger Tebartz van Elst; Dominique Endres
Journal:  Diagnostics (Basel)       Date:  2021-06-22

8.  Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders.

Authors:  Christian Scheiber; Tanja Schulz; Julian M Schneider; Karl Bechter; E Marion Schneider
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28

9.  Alterations in circulating extracellular vesicles underlie social stress-induced behaviors in mice.

Authors:  Shinji Sakamoto; Dania Mallah; Destynie J Medeiros; Eisuke Dohi; Takashi Imai; Indigo V L Rose; Ken Matoba; Xiaolei Zhu; Atsushi Kamiya; Shin-Ichi Kano
Journal:  FEBS Open Bio       Date:  2021-06-24       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.